Skip to main content
SpringerLink
Log in

Diabetes and Cardiovascular Disease

  • Reference work entry
  • First Online:
Handbook of Cardiovascular Behavioral Medicine

  • 799 Accesses

Abstract

Diabetes mellitus is associated with high rates of cardiovascular disease (e.g., atherosclerosis, ischemic heart disease, congestive heart failure, myocardial infarction) and cardiovascular mortality. Behaviors including smoking, physical inactivity, and sedentary lifestyle, as well as overweight and obesity, increase the risk of type 2 diabetes. Several large clinical trials have demonstrated definitively the effectiveness of lifestyle modification (e.g., diet, physical activity) in preventing or delaying type 2 diabetes. Similarly, behavioral interventions to improve self-management behaviors for blood sugar, blood pressure, and lipids can be effective in improving outcomes. Prevalent psychosocial and behavioral health issues (e.g., depression, anxiety) increase complexity of diabetes care and necessitate collaborative care approaches that target diabetes, cardiovascular, and behavioral health outcomes simultaneously.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
eBook
USD 549.99
Price excludes VAT (USA)
Hardcover Book
USD 329.99
Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ami Laws (1999) Insulin resistance and dyslipidemia. In: Reaven GM (ed) Insulin resistance. The metabolic syndrome X, 1st edn. Humana Press, pp 267–280

    Google Scholar 

  2. Abraham TM, Pencina KM, Pencina MJ, Fox CS (2015) Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care 38:482–487

    Article  PubMed  Google Scholar 

  3. Action to Control Cardiovascular Risk in Diabetes Study G, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559

    Article  Google Scholar 

  4. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412–419

    Article  PubMed  PubMed Central  Google Scholar 

  5. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR (2002) UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894–899

    Article  PubMed  Google Scholar 

  6. American Diabetes A (2016) 2. Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 1):S13–S22

    Article  Google Scholar 

  7. Arauz-Pacheco C, Parrott MA, Raskin P (2002) The treatment of hypertension in adult patients with diabetes. Diabetes Care 25:134–147

    Article  PubMed  Google Scholar 

  8. Assmann G, Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70:733–737

    Article  PubMed  Google Scholar 

  9. Assmann G, Schulte H, Funke H, von Eckardstein A (1998) The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 19(Suppl M):M8–M14

    PubMed  Google Scholar 

  10. Association AD. American Diabetes Association (2016) Standards of medical care – 2016. Am Diabetes Assoc 39(Suppl 1):S23–S35, S52–S71

    Google Scholar 

  11. Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R et al (2004) The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study. J Am Coll Cardiol 43:2236–2241

    Article  PubMed  Google Scholar 

  12. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27:699–703

    Article  PubMed  Google Scholar 

  13. Blake GJ, Otvos JD, Rifai N, Ridker PM (2002) Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106:1930–1937

    Article  PubMed  Google Scholar 

  14. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The framingham study. JAMA 256:2835–2838

    Article  PubMed  Google Scholar 

  15. Chen L, Pei JH, Kuang J, Chen HM, Chen Z, Li ZW, Yang HZ (2015) Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism 64:338–347

    Article  PubMed  Google Scholar 

  16. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J et al (2014) Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311:1778–1786

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7

    Article  PubMed  Google Scholar 

  18. de Groot M, Golden SH, Wagner J (2016) Psychological conditions in adults with diabetes. Am Psychol 71:552–562

    Article  PubMed  PubMed Central  Google Scholar 

  19. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952–957

    Article  PubMed  Google Scholar 

  20. Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ (2009) Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 169:1307–1316

    Article  Google Scholar 

  21. Diabetes Prevention Program Research G (2002) The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165–2171

    Article  Google Scholar 

  22. Diabetes Prevention Program Research G, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677–1686

    Article  Google Scholar 

  23. Diet N, and the Prevention of Chronic Diseases (2003) Report of a WHO Study Group Geneva, World Health Organization. WHO Technical Report Series, 916 – TRS 916: i–viii, 1–149, backcover

    Google Scholar 

  24. Eliasson B (2003) Cigarette smoking and diabetes. Prog Cardiovasc Dis 45:405–413

    Article  PubMed  Google Scholar 

  25. Eriksson KF, Lindgarde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 34:891–898

    Article  PubMed  Google Scholar 

  26. Fitzpatrick SL, Golden SH, Stewart K, Sutherland J, DeGross S, Brown T et al (2016) Effect of DECIDE (decision-making education for choices in diabetes everyday) program delivery modalities on clinical and behavioral outcomes in urban African Americans With type 2 diabetes: a randomized trial. Diabetes Care 39:2149–2157

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875–881

    Article  PubMed  Google Scholar 

  28. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y et al (2014) Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312:1218–1226

    Article  PubMed  Google Scholar 

  29. Goldbourt U, Yaari S (1990) Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel. Arteriosclerosis 10:512–519

    Article  PubMed  Google Scholar 

  30. Golden SH, Wang NY, Klag MJ, Meoni LA, Brancati FL (2003) Blood pressure in young adulthood and the risk of type 2 diabetes in middle age. Diabetes Care 26:1110–1115

    Article  PubMed  Google Scholar 

  31. Golden SH, Selvin E, Cunningham KE (2007) Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention. Diabetes Obes Metab 9:792–798

    Article  PubMed  Google Scholar 

  32. Group NDD (1995) Diabetes in America, 2nd edn. National Institutes of Health

    Google Scholar 

  33. Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297

    Article  PubMed  Google Scholar 

  34. Haffner SM (2002) Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 90:55i–61i

    Article  PubMed  Google Scholar 

  35. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893–2898

    Article  PubMed  Google Scholar 

  36. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234

    Article  PubMed  Google Scholar 

  37. Haffner SM, D’Agostino R Jr, Mykkanen L, Tracy R, Howard B, Rewers M et al (1999) Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the insulin resistance atherosclerosis study. Diabetes Care 22:562–568

    Article  PubMed  Google Scholar 

  38. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP (2000) Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101:975–980

    Article  PubMed  Google Scholar 

  39. Haire-Joshu D, Glasgow RE, Tibbs TL (1999) Smoking and diabetes. Diabetes Care 22:1887–1898

    Article  PubMed  Google Scholar 

  40. Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598–612

    Article  PubMed  PubMed Central  Google Scholar 

  41. Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, Bower P (2010) Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care 33:926–930

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hill-Briggs F, Lazo M, Peyrot M, Doswell A, Chang YT, Hill MN et al (2011) Effect of problem-solving-based diabetes self-management training on diabetes control in a low income patient sample. J Gen Intern Med 26:972–978

    Article  PubMed  PubMed Central  Google Scholar 

  43. Huttunen JK, Manninen V, Manttari M, Koskinen P, Romo M, Tenkanen L et al (1991) Helsinki heart study: central findings and clinical implications. Ann Med 23:155–159

    Article  PubMed  Google Scholar 

  44. Karnchanasorn R, Huang J, Ou HY, Feng W, Chuang LM, Chiu KC, Samoa R (2016) Comparison of the current diagnostic criterion of HbA1c with fasting and 2-hour plasma glucose concentration. J Diabetes Res 2016:6195494

    Article  PubMed  PubMed Central  Google Scholar 

  45. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research G (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403

    Article  PubMed  Google Scholar 

  46. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ (1986) Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332–1339

    Article  PubMed  Google Scholar 

  47. Krauss RM (2004) Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27:1496–1504

    Article  PubMed  Google Scholar 

  48. Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. Am J Ophthalmol 129:704–705

    Article  Google Scholar 

  49. Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Despres JP (2001) A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol 17:859–865

    PubMed  Google Scholar 

  50. Lehto S, Ronnemaa T, Pyorala K, Laakso M (2000) Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 43:148–155

    Article  PubMed  Google Scholar 

  51. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100:123–128

    Article  PubMed  Google Scholar 

  52. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783–1789

    Article  PubMed  Google Scholar 

  53. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, Heiss G (1999) Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis risk in communities study investigators. J Hypertens 17:1169–1177

    Article  PubMed  Google Scholar 

  54. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679

    Article  PubMed  Google Scholar 

  55. Lindstrom J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U et al (2010) Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 42(Suppl 1):S37–S55

    Article  PubMed  Google Scholar 

  56. McPhillips JB, Barrett-Connor E, Wingard DL (1990) Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131:443–453

    Article  PubMed  Google Scholar 

  57. Meigs JB, D’Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE (1997) Risk variable clustering in the insulin resistance syndrome. The framingham offspring study. Diabetes 46:1594–1600

    Article  PubMed  Google Scholar 

  58. Menke A, Casagrande S, Geiss L, Cowie CC (2015) Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 314:1021–1029

    Article  PubMed  Google Scholar 

  59. Montane J, Cadavez L, Novials A (2014) Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 7:25–34

    PubMed  PubMed Central  Google Scholar 

  60. Nabulsi AA, Folsom AR, Heiss G, Weir SS, Chambless LE, Watson RL, Eckfeldt JH (1995) Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis risk in communities study investigators. Metabolism 44:914–922

    Article  PubMed  Google Scholar 

  61. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Diabetes C, Complications Trial/Epidemiology of Diabetes I and Complications Study Research G (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653

    Article  PubMed  Google Scholar 

  62. Ostman J, Lonnberg G, Arnqvist HJ, Blohme G, Bolinder J, Ekbom Schnell A et al (2008) Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002. J Intern Med 263:386–394

    Article  PubMed  Google Scholar 

  63. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544

    Article  PubMed  Google Scholar 

  64. Peters SA, Huxley RR, Woodward M (2014) Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57:1542–1551

    Article  PubMed  Google Scholar 

  65. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention P (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297

    Article  PubMed  Google Scholar 

  66. Reaven GM (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37:1595–1607

    Article  PubMed  Google Scholar 

  67. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al (2011) Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 123:e18–e209

    Article  PubMed  Google Scholar 

  68. Roheim PS, Asztalos BF (1995) Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem 41:147–152

    Article  PubMed  Google Scholar 

  69. Samuel-Hodge CD, Hill-Briggs F, Gary TL (2006) Lifestyle intervention for prevention and treatment of type 2 diabetes. Nurs Clin N Am 41:567–588, vii

    Article  Google Scholar 

  70. Sh G (2009) The cardiovascular consequences of type 2 diabetes mellitus. In: Regensteiner J, Reusch J, Stewart K, Kelly D (eds) Diabetes and exercise. Humana Press, pp 109–132

    Google Scholar 

  71. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP et al (2015) Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol 3:105–113

    Article  PubMed  PubMed Central  Google Scholar 

  72. Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588

    Article  PubMed  Google Scholar 

  73. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH (1996) A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276:882–888

    Article  PubMed  Google Scholar 

  74. Stern MP (1995) Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 44:369–374

    Article  PubMed  Google Scholar 

  75. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412

    Article  PubMed  PubMed Central  Google Scholar 

  76. Temelkova-Kurktschiev T, Hanefeld M (2004) The lipid triad in type 2 diabetes – prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes 112:75–79

    Article  PubMed  Google Scholar 

  77. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986

    Article  Google Scholar 

  78. Tovote KA, Fleer J, Snippe E, Peeters AC, Emmelkamp PM, Sanderman R et al (2014) Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial. Diabetes Care 37:2427–2434

    Article  PubMed  Google Scholar 

  79. Tuomilehto J, Schwarz PE (2010) Primary prevention of type 2 diabetes is advancing towards the mature stage in Europe. Horm Metab Res 42(Suppl 1):S1–S2

    Article  PubMed  Google Scholar 

  80. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350

    Article  PubMed  Google Scholar 

  81. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316:823–828

    Article  PubMed  PubMed Central  Google Scholar 

  82. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Article  Google Scholar 

  83. Wandell PE, Carlsson AC (2014) Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden – a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract 106:e90–e92

    Article  PubMed  Google Scholar 

  84. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664

    Article  PubMed  Google Scholar 

  85. Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M (2016) Psychosocial care for people with diabetes: a position statement of the american diabetes association. Diabetes Care 39:2126–2140

    Article  PubMed  PubMed Central  Google Scholar 

  86. Zhang CY, Sun AJ, Zhang SN, Wu CN, Fu MQ, Xia G, Wang KQ, Zou YZ, Ge JB (2010) Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis. Ann Med 42:305–315

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Preparation of this chapter was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) Diabetes Research Center grant P30 DK079637.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of General Internal Medicine, and Department of Health, Behavior, and Society, and Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Felicia Hill-Briggs

  2. Department of Medicine, Division of Endocrinology and Metabolism and Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Mohammad Naqibuddin

  3. Department of Medicine, Division of Endocrinology and Metabolism, and Department of Epidemiology, and the Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Sherita Hill Golden

Authors
  1. Felicia Hill-Briggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Naqibuddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sherita Hill Golden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Felicia Hill-Briggs .

Editor information

Editors and Affiliations

  1. Department of Psychology, University of Maryland, Baltimore County, Baltimore, MD, USA

    Shari R. Waldstein

  2. Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands

    Willem J. Kop

  3. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

    Edward C. Suarez

  4. Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    William R. Lovallo

  5. Division of Gerontology Geriatrics and Palliative Medicine Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    Leslie I. Katzel

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Hill-Briggs, F., Naqibuddin, M., Golden, S.H. (2022). Diabetes and Cardiovascular Disease. In: Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., Katzel, L.I. (eds) Handbook of Cardiovascular Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85960-6_58

Download citation

Publish with us

Policies and ethics

Search

Navigation